Adherence to the standard dose of imatinib, rather than dose adjustment based on its plasma concentration, is critical to achieve a deep molecular response in patients with chronic myeloid leukemia

✍ Scribed by Chikashi Yoshida; Takuya Komeno; Mitsuo Hori; Tomofumi Kimura; Masami Fujii; Yasushi Okoshi; Kazumi Suzukawa; Shigeru Chiba; Yuichi Hasegawa; Harumi Yamamoto Mukai; Takayoshi Ito; Seiichi Shimizu; Masaharu Kamoshita; Daisuke Kudo; Atsushi Shinagawa; Norio Chikatsu; Yuriko Monma; Norimichi Watanabe; Hiroshi Kojima

• Book ID: 107619283
• Publisher: Carden Jennings Publishing
• Year: 2011
• Tongue: English
• Weight: 162 KB
• Volume: 93
• Category: Article
• ISSN: 0925-5710
• DOI: 10.1007/s12185-011-0838-3